Otros idiomas Amphastar Pharmaceuticals, Inc.

Acciones

AMPH

US03209R1032

Tiempo real estimado Cboe BZX Otros sitios de cotización 16:44:01 07/05/2024			Varia. Cinco días.	Varia. 1 de enero.
42 ^USD	-1,59 %		+2,74 %	-31,48 %

30/04	La FTC impugna los listados de patentes "basura" de Ozempic, Victoza y otros medicamentos	MT
30/04	Las noticias del mediodía: Las acciones de Eli Lilly y HSBC se disparan tras los resultados; BBVA explora una fusión con Sabadell; la FTC impugna 300 listados de patentes "basura	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

HINTERGRUND/FTC knöpft sich Patentanmeldungen für Arzneimittel vor	01/05
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	30/04
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Amphastar Pharmaceuticals Insider Sold Shares Worth $842,883, According to a Recent SEC Filing	08/03
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023	29/02
Sector Update: Health Care Stocks Advance Premarket Thursday	29/02
Amphastar Pharmaceuticals Q4 Adjusted Earnings, Revenue Rise	29/02
Amphastar Pharmaceuticals, Inc. Reports Impairment of Long-Lived Assets for the Fourth Quarter Ended December 31, 2023	28/02
Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Amphastar: Q4 Earnings Snapshot	28/02
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Posts Q4 EPS $0.88, vs. Street Est of $0.91	28/02
Earnings Flash (AMPH) AMPHASTAR PHARMACEUTICALS Reports Q4 Revenue $178.1M, vs. Street Est of $173.3M	28/02
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024	21/02
High-dose opioid reversal spray no better than lower dose in field, US study finds	08/02
Amphastar Pharmaceuticals Insider Sold Shares Worth $7,171,768, According to a Recent SEC Filing	11/01
Amphastar Pharmaceuticals Insider Sold Shares Worth $12,798,708, According to a Recent SEC Filing	11/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Amphastar Pharmaceuticals, Inc.

Acciones

AMPH

US03209R1032

Otros idiomas

Filtros